Blue Rebecca S, Bayuse Tina M, Daniels Vernie R, Wotring Virginia E, Suresh Rahul, Mulcahy Robert A, Antonsen Erik L
1Aerospace Medicine and Vestibular Research Laboratory, The Mayo Clinic Arizona, Scottsdale, AZ 85054 USA.
2GeoControl Systems, Inc, Houston, TX 77058 USA.
NPJ Microgravity. 2019 Jun 13;5:14. doi: 10.1038/s41526-019-0075-2. eCollection 2019.
In order to maintain crew health and performance during long-duration spaceflight outside of low-Earth orbit, NASA and its international partners must be capable of providing a safe and effective pharmacy. Given few directed studies of pharmaceuticals in the space environment, it is difficult to characterize pharmaceutical effectiveness or stability during spaceflight; this in turn makes it challenging to select an appropriate formulary for exploration. Here, we present the current state of literature regarding pharmaceutical stability, metabolism, and effectiveness during spaceflight. In particular, we have attempted to highlight the gaps in current knowledge and the difficulties in translating terrestrial-based drug studies to a meaningful interpretation of drug stability, safety, and effectiveness in space. We hope to identify high-yield opportunities for future research that might better define and mitigate pharmaceutical risk for exploration missions.
为了在低地球轨道以外的长期太空飞行中维持机组人员的健康和工作表现,美国国家航空航天局(NASA)及其国际合作伙伴必须有能力提供一个安全有效的药房。鉴于针对太空环境中药物的定向研究较少,很难确定药物在太空飞行期间的有效性或稳定性;这反过来又使得为探索任务选择合适的配方具有挑战性。在此,我们介绍了有关太空飞行期间药物稳定性、代谢和有效性的文献现状。特别是,我们试图突出当前知识的空白,以及将基于地面的药物研究转化为对太空药物稳定性、安全性和有效性的有意义解释所面临的困难。我们希望确定未来研究的高产机会,以便更好地界定和减轻探索任务的药物风险。